BR0205096A - Composição dermatológica, processo de tratamento cosmetológico e utilização do ácido nicotìnico ou de uma amida de ácido nicotìnico tal como a vitamina pp e de uma base esfingóide - Google Patents

Composição dermatológica, processo de tratamento cosmetológico e utilização do ácido nicotìnico ou de uma amida de ácido nicotìnico tal como a vitamina pp e de uma base esfingóide

Info

Publication number
BR0205096A
BR0205096A BR0205096-0A BR0205096A BR0205096A BR 0205096 A BR0205096 A BR 0205096A BR 0205096 A BR0205096 A BR 0205096A BR 0205096 A BR0205096 A BR 0205096A
Authority
BR
Brazil
Prior art keywords
nicotinic acid
vitamin
dermatological composition
treatment process
acid amide
Prior art date
Application number
BR0205096-0A
Other languages
English (en)
Inventor
Jean-Claude Allart
Jean-Marie Lefevre
Jacques Peyrot
Original Assignee
Dermaconcept Jmc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8862592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0205096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dermaconcept Jmc filed Critical Dermaconcept Jmc
Publication of BR0205096A publication Critical patent/BR0205096A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO DERMATOLóGICA, PROCESSO DE TRATAMENTO COSMETOLóGICO E UTILIZAçãO DO áCIDO NICOTìNICO OU DE UMA AMIDA DE áCIDO NICOTìNICO TAL COMO A VITAMINA PP E DE UMA BASE ESFINGóIDE". A invenção refere-se a uma composição dermatológica. A composição dermatológica compreende em combinação pelo menos o ácido nicotínico ou uma amida do ácido nicotínico tal como a nicotinamida (vitamina PP) e pelo menos uma base esfingóide escolhida entre a esfingosina, a esfinganina, a fitoesfingosina, a tetraacetilfitoesfingosina, a N-acetilfitoesfingosina e o cloridrato de fitoesfingosina. Aplicação ao tratamento da dermatite atópica e da acne.
BR0205096-0A 2001-04-23 2002-04-17 Composição dermatológica, processo de tratamento cosmetológico e utilização do ácido nicotìnico ou de uma amida de ácido nicotìnico tal como a vitamina pp e de uma base esfingóide BR0205096A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105451A FR2823671B1 (fr) 2001-04-23 2001-04-23 Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide
PCT/FR2002/001330 WO2002085362A2 (fr) 2001-04-23 2002-04-17 Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoïde.

Publications (1)

Publication Number Publication Date
BR0205096A true BR0205096A (pt) 2003-03-25

Family

ID=8862592

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0205096-0A BR0205096A (pt) 2001-04-23 2002-04-17 Composição dermatológica, processo de tratamento cosmetológico e utilização do ácido nicotìnico ou de uma amida de ácido nicotìnico tal como a vitamina pp e de uma base esfingóide

Country Status (17)

Country Link
US (1) US20040170591A1 (pt)
EP (1) EP1404327B1 (pt)
AT (1) ATE331516T1 (pt)
AU (1) AU2002304546A1 (pt)
BR (1) BR0205096A (pt)
CA (1) CA2443939A1 (pt)
CY (1) CY1106442T1 (pt)
DE (1) DE60212842T2 (pt)
DZ (1) DZ3504A1 (pt)
ES (1) ES2263781T3 (pt)
FR (1) FR2823671B1 (pt)
IL (1) IL158455A0 (pt)
MA (1) MA27014A1 (pt)
PT (1) PT1404327E (pt)
RU (1) RU2297224C2 (pt)
TN (1) TNSN03102A1 (pt)
WO (1) WO2002085362A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1684675A (zh) * 2002-08-14 2005-10-19 金泰润 用于诱导细胞凋亡的含有植物鞘氨醇衍生物的组合物
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
EP3061501A1 (en) * 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
WO2021204223A1 (zh) * 2020-04-08 2021-10-14 扬子江药业集团南京海陵药业有限公司 一种包含烟酰胺的药物组合物
CA3231023A1 (en) * 2021-09-15 2023-03-23 Nat Adkins Ointments for treating dry skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
JP3508042B2 (ja) * 1995-04-17 2004-03-22 カネボウ株式会社 セラミド合成促進剤
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
DE19810999A1 (de) * 1998-03-13 1999-09-16 Dermapharm Gmbh Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten
EP1063964A1 (en) * 1998-03-16 2001-01-03 The Procter & Gamble Company Moisturizing compositions
JP3884581B2 (ja) * 1998-10-05 2007-02-21 花王株式会社 ニキビ予防・改善剤
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Also Published As

Publication number Publication date
WO2002085362A3 (fr) 2004-01-22
MA27014A1 (fr) 2004-12-20
FR2823671B1 (fr) 2004-01-09
TNSN03102A1 (fr) 2005-12-23
ES2263781T3 (es) 2006-12-16
PT1404327E (pt) 2006-10-31
US20040170591A1 (en) 2004-09-02
EP1404327B1 (fr) 2006-06-28
IL158455A0 (en) 2004-05-12
DZ3504A1 (fr) 2002-10-31
RU2003133986A (ru) 2005-03-10
AU2002304546A1 (en) 2002-11-05
FR2823671A1 (fr) 2002-10-25
DE60212842D1 (de) 2006-08-10
CA2443939A1 (fr) 2002-10-31
ATE331516T1 (de) 2006-07-15
DE60212842T2 (de) 2007-06-28
WO2002085362A2 (fr) 2002-10-31
EP1404327A2 (fr) 2004-04-07
CY1106442T1 (el) 2011-10-12
RU2297224C2 (ru) 2007-04-20

Similar Documents

Publication Publication Date Title
BRPI0316438C1 (pt) uso de eritropoietina em doenças cardíacas
DE69814146D1 (de) Topische zusammensetzungen zur kontrolle von öligem/glänzenden aussehen der haut
AR069020A1 (es) Composicion para el cuidado del cabello
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
TNSN04039A1 (en) Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators
ATE280154T1 (de) Verzweigte alkylpyrrolidin-3-carbonsäuren
NO20061277L (no) Farmasoytiske sammensetninger omfattende malonamidderivater for redusering av sebum produksjon
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
MXPA05003490A (es) Metodo de tratamiento de las fibras del cabello y uso de este metodo.
BR0205096A (pt) Composição dermatológica, processo de tratamento cosmetológico e utilização do ácido nicotìnico ou de uma amida de ácido nicotìnico tal como a vitamina pp e de uma base esfingóide
PL1979521T3 (pl) Nowy sposób impregnowania powierzchni tekstylnych
DE60124715D1 (de) Er produktion von beta-endorphin
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
ZA957507B (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
DE69717849T2 (de) Lektinzusammenstellungen und deren verwendung
BR0204911A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de preparação de uma composição. processo e dispositivo com dois compartimentos ou 'kit' para a descoloração ou a deformação permanente das fibras queratìnicas humanas
SI1744736T1 (sl) Postopek za zdravljenje težav s suhimi očmi in uveitisa
BR0307910A (pt) Composição de soja para equilibrar pele mista
FR2804321B1 (fr) Utilisation de derives de polyaminoacides pour traiter la seborrhee et les desordres cutanes associes
EP1546377A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING MOLECULES 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 OR 13424
PL1495753T3 (pl) Zastosowanie (2S,3R,4S)-4-hydroksyizoleucyny w kompozycjach kosmetycznych do stosowania miejscowego
MXPA05003488A (es) Metodo de tratamiento de las fibras del cabello y uso de este metodo.
BR0317925A (pt) Utilização de uma molécula ativa, composição cosmética e processo de tratamento da celulite
BRPI0408743A (pt) formulações compreendendo tolterodina e cacau em pó e sua utilização

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A., E 9A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/133 (2006.01), A61K 31/4412 (2006.01), A61